Frassineti GL - Search Results

1

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.

Marisi G, Azzali I, Passardi A, Rebuzzi F, Bartolini G, Urbini M, Canale M, Molinari C, Matteucci L, Sullo FG, Debonis SA, Gallio C, Gallo G, Frassineti GL, Ulivi P. Marisi G, et al. Among authors: frassineti gl. Sci Rep. 2023 Aug 9;13(1):12921. doi: 10.1038/s41598-023-40220-7. Sci Rep. 2023. PMID: 37558720 Free PMC article. Clinical Trial.

2

Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer.

Montanari M, Fabbri F, Rondini E, Frassineti GL, Mattioli R, Carloni S, Scarpi E, Zoli W, Amadori D, Cruciani G. Montanari M, et al. Among authors: frassineti gl. Tumori. 2012 Nov;98(6):696-701. doi: 10.1177/030089161209800604. Tumori. 2012. PMID: 23389354 Clinical Trial.

3

A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.

Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E. Amadori D, et al. Among authors: frassineti gl. Semin Oncol. 1996 Oct;23(5 Suppl 11):16-22. Semin Oncol. 1996. PMID: 8893894 Clinical Trial.

4

A Phase I/II study of paclitaxel and doxorubicin in the treatment of advanced breast cancer.

Amadori D, Frassineti GL, Zoli W, Tienghi A, Ravaioli A, Casadei Giunchi D, Gentile A, Salzano E. Amadori D, et al. Among authors: frassineti gl. Semin Oncol. 1996 Feb;23(1 Suppl 1):19-23. Semin Oncol. 1996. PMID: 8629031 Clinical Trial.

5

Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study.

Dazzi C, Cariello A, Rosti G, Tienghi A, Molino A, Sabbatini R, Aieta M, Frassineti GL, Vertogen B, Giovanis P, Marangolo M. Dazzi C, et al. Among authors: frassineti gl. Haematologica. 2001 May;86(5):523-9. Haematologica. 2001. PMID: 11410417 Clinical Trial.

6

In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.

Zoli W, Flamigni A, Frassineti GL, Bajorko P, De Paola F, Milandri C, Amadori D, Gasperi-Campani A. Zoli W, et al. Among authors: frassineti gl. Breast Cancer Res Treat. 1995 Apr;34(1):63-9. doi: 10.1007/BF00666492. Breast Cancer Res Treat. 1995. PMID: 7749161

7

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.

Aschele C, Guglielmi A, Frassineti GL, Milandri C, Amadori D, Labianca R, Vinci M, Tixi L, Caroti C, Ciferri E, Verdi E, Rosso R, Sobrero A. Aschele C, et al. Among authors: frassineti gl. Br J Cancer. 1998;77(2):341-6. doi: 10.1038/bjc.1998.53. Br J Cancer. 1998. PMID: 9461008 Free PMC article. Clinical Trial.

8

In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.

Savini S, Zoli W, Nanni O, Volpi A, Frassineti GL, Magni E, Flamigni A, Amadori A, Amadori D. Savini S, et al. Among authors: frassineti gl. Breast Cancer Res Treat. 1992;24(1):27-34. doi: 10.1007/BF01832355. Breast Cancer Res Treat. 1992. PMID: 1463869

9

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.

Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassineti GL, Aschele C, Ravaioli A, Testore P, Caroti C, Gallo L, Pessi MA, Cortesi E, Turci D, Grossi F, Labianca R. Sobrero A, et al. Among authors: frassineti gl. Br J Cancer. 2001 Apr 20;84(8):1023-8. doi: 10.1054/bjoc.2001.1732. Br J Cancer. 2001. PMID: 11308248 Free PMC article. Clinical Trial.

10

Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.

Ibrahim T, Zoli W, Frassineti GL, Tesei A, Colantonio I, Monti M, Amadori D. Ibrahim T, et al. Among authors: frassineti gl. Lung Cancer. 2005 Feb;47(2):261-7. doi: 10.1016/j.lungcan.2004.06.011. Lung Cancer. 2005. PMID: 15639725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page